Compare OGN & ICHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OGN | ICHR |
|---|---|---|
| Founded | 1923 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.6B |
| IPO Year | 2020 | 2016 |
| Metric | OGN | ICHR |
|---|---|---|
| Price | $5.85 | $44.78 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 6 |
| Target Price | $11.75 | ★ $45.67 |
| AVG Volume (30 Days) | ★ 3.0M | 636.3K |
| Earning Date | 04-30-2026 | 05-04-2026 |
| Dividend Yield | ★ 1.32% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.72 | N/A |
| Revenue | ★ $6,216,000,000.00 | $947,652,000.00 |
| Revenue This Year | $0.42 | $19.98 |
| Revenue Next Year | $1.67 | $15.92 |
| P/E Ratio | $8.42 | ★ N/A |
| Revenue Growth | N/A | ★ 11.61 |
| 52 Week Low | $5.76 | $13.15 |
| 52 Week High | $14.94 | $55.00 |
| Indicator | OGN | ICHR |
|---|---|---|
| Relative Strength Index (RSI) | 25.56 | 49.62 |
| Support Level | N/A | $15.74 |
| Resistance Level | $7.87 | $55.00 |
| Average True Range (ATR) | 0.22 | 3.39 |
| MACD | 0.00 | -0.34 |
| Stochastic Oscillator | 10.00 | 31.89 |
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.
Ichor Holdings Ltd designs, engineers, and manufactures critical fluid delivery subsystems and components mainly for semiconductor capital equipment, along with solutions for defense/aerospace and medical industries. Its product portfolio includes gas and chemical delivery subsystems that enable precise delivery, monitoring, and control of specialized gases and reactive liquid chemistries used in semiconductor manufacturing processes such as etch, electroplating, and cleaning. The company also provides precision-machined components, weldments, e-beam and laser-welded components, as well as precision vacuum and hydrogen brazing. Geographically, the company operates across the United States, Singapore, Europe, and other regions, with Singapore contributing the majority of revenue.